EBS - Emergent BioSolutions Inc.

NYSE - NYSE Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 52.47B
Enterprise Value 33.15B
Trailing P/E 39.61
Forward P/E 114.51
PEG Ratio (5 yr expected) 11.59
Price/Sales (ttm)3.16
Price/Book (mrq)2.45
Enterprise Value/Revenue 34.03
Enterprise Value/EBITDA 618.24

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Dec 31, 2018

Profitability

Profit Margin 8.01%
Operating Margin (ttm)14.14%

Management Effectiveness

Return on Assets (ttm)4.19%
Return on Equity (ttm)6.52%

Income Statement

Revenue (ttm)782.4M
Revenue Per Share (ttm)15.62
Quarterly Revenue Growth (yoy)39.70%
Gross Profit (ttm)460.1M
EBITDA 172.8M
Net Income Avi to Common (ttm)62.7M
Diluted EPS (ttm)1.22
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)112.2M
Total Cash Per Share (mrq)2.19
Total Debt (mrq)794.6M
Total Debt/Equity (mrq)78.60
Current Ratio (mrq)3.10
Book Value Per Share (mrq)19.74

Cash Flow Statement

Operating Cash Flow (ttm)41.8M
Levered Free Cash Flow (ttm)-35.06M

Trading Information

Stock Price History

Beta (3Y Monthly) 1.47
52-Week Change 3-7.46%
S&P500 52-Week Change 310.30%
52 Week High 373.89
52 Week Low 346.93
50-Day Moving Average 359.20
200-Day Moving Average 362.58

Share Statistics

Avg Vol (3 month) 3464.75k
Avg Vol (10 day) 3892.64k
Shares Outstanding 551.2M
Float 43.54M
% Held by Insiders 114.79%
% Held by Institutions 185.53%
Shares Short (Feb 28, 2019) 43.05M
Short Ratio (Feb 28, 2019) 48.52
Short % of Float (Feb 28, 2019) 47.25%
Short % of Shares Outstanding (Feb 28, 2019) 45.96%
Shares Short (prior month Jan 31, 2019) 42.93M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A